Effects of pamidronate on human alveolar osteoblasts in vitro

Journal of Oral and Maxillofacial Surgery

Volumn 70, Issue 5, 2012, Pages 1081-1092

  Marolt, Darja ^a   Cozin, Matthew ^a   Vunjak Novakovic, Gordana ^a   Cremers, Serge ^b   Landesberg, Regina ^c  

^a Vanderbilt Clinic ^*  (United States)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4',6 DIAMIDINO 2 PHENYLINDOLE; ALKALINE PHOSPHATASE; CASPASE 3; PAMIDRONIC ACID;

ALVEOLAR BONE; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL POPULATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; ILIAC BONE; JAW OSTEONECROSIS; LONG BONE; NICK END LABELING; OSTEOBLAST; STROMA CELL; WOUND HEALING;

ALKALINE PHOSPHATASE; ALVEOLAR PROCESS; APOPTOSIS; BONE DENSITY CONSERVATION AGENTS; BONE MARROW CELLS; BONE REMODELING; CASPASE 3; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DIPHOSPHONATES; DOSE-RESPONSE RELATIONSHIP, DRUG; FLUORESCENT DYES; HUMANS; IN SITU NICK-END LABELING; INDOLES; OSTEOBLASTS; OSTEOGENESIS; STROMAL CELLS; TIME FACTORS; WOUND HEALING;

EID: 84860228669     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2011.05.002     Document Type: Article

References (47)

1. R.E. Marx, Y. Sawatari, M. Fortin, V. Broumand Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: Risk factors, recognition, prevention, and treatment J Oral Maxillofac Surg 63 2005 1567
2. S.L. Ruggiero, T.B. Dodson, L.A. Assael American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws - 2009 update J Oral Maxillofac Surg 67 2009 2
3. S. Khosla, D. Burr, J. Cauley Bisphosphonate-associated osteonecrosis of the jaw: Report of a task force of the American Society for Bone and Mineral Research J Bone Miner Res 22 2007 1479
4. R.A. Kyle, G.C. Yee, M.R. Somerfield American Society of Clinical Oncology Clinical practice guideline update on the role of bisphosphonates in multiple myeloma J Clin Oncol 25 2007 2464
5. V. Patel, N.M. McLeod, S.N. Rogers Bisphosphonate osteonecrosis of the jaw - a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention Br J Oral Maxillofac Surg 2010
6. S.L. Ruggiero, T.B. Dodson, L.A. Assael American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw - 2009 update Aust Endod J 35 2009 119
7. S.L. Ruggiero, J. Fantasia, E. Carlson Bisphosphonate-related osteonecrosis of the jaw: Background and guidelines for diagnosis, staging and management Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102 2006 433
8. T. Yoneda, H. Hagino, T. Sugimoto Bisphosphonate-related osteonecrosis of the jaw: Position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology and Japanese Society of Oral and Maxillofacial Surgeons J Bone Miner Metab 28 2010 365
9. P. Lesclous, S. Abi-Najm, J.P. Carrel Bisphosphonate-associated osteonecrosis of the jaw: A key role of inflammation? Bone 45 2009 843
10. S.O. Akintoye, T. Lam, S. Shi Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals Bone 38 2006 758
11. V. Everts, W. Korper, K.A. Hoeben Osteoclastic bone degradation and the role of different cysteine proteinases and matrix metalloproteinases: Differences between calvaria and long bone J Bone Miner Res 21 2006 1399
12. S. Suttapreyasri, S. Koontongkaew, A. Phongdara, U. Leggat Expression of bone morphogenetic proteins in normal human intramembranous and endochondral bones Int J Oral Maxillofac Surg 35 2006 444
13. T. van den Bos, D. Speijer, R.A. Bank, D. Brmme, V. Everts Differences in matrix composition between calvaria and long bone in mice suggest differences in biomechanical properties and resorption: Special emphasis on collagen Bone 43 2008 459
14. D. Stefanik, J. Sarin, T. Lam Disparate osteogenic response of mandible and iliac crest bone marrow stromal cells to pamidronate Oral Dis 14 2008 465
15. N. Giuliani, M. Pedrazzoni, G. Negri Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo Bone 22 1998 455
16. G.I. Im, S.A. Qureshi, J. Kenney Osteoblast proliferation and maturation by bisphosphonates Biomaterials 25 2004 4105
17. G.G. Reinholz, B. Getz, L. Pederson Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts Cancer Res 60 2000 6001
18. F. von Knoch, C. Jaquiery, M. Kowalsky Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells Biomaterials 26 2005 6941
19. C. Garcia-Moreno, S. Serrano, M. Nacher Effect of alendronate on cultured normal human osteoblasts Bone 22 1998 233
20. M. Kellinsalmi, H. Monkkonen, J. Monkkonen In vitro comparison of clodronate, pamidronate and zoledronic acid effects on rat osteoclasts and human stem cell-derived osteoblasts Basic Clin Pharmacol Toxicol 97 2005 382
21. C. Walter, M.O. Klein, A. Pabst Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells Clin Oral Investig 14 2010 35
22. Cozin M, Pinker BM, Solemani K, et al. Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts. J Oral Maxillofac Surg, in press
23. R.H. Kim, R.S. Lee, D. Williams Bisphosphonates induce senescence in normal human oral keratinocytes J Dent Res 90 2011 810
24. R. Landesberg, M. Cozin, S. Cremers Inhibition of oral mucosal cell wound healing by bisphosphonates J Oral Maxillofac Surg 66 2008 839
25. C. Walter, A. Pabst, T. Ziebart Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro Oral Dis 17 2010 194
26. T. Ziebart, A. Pabst, M.O. Klein Bisphosphonates: Restrictions for vasculogenesis and angiogenesis: Inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro Clin Oral Investig 15 2011 105
27. S.C. Cremers, S.E. Papapoulos, H. Gelderblom Skeletal retention of bisphosphonate (pamidronate) and its relation to the rate of bone resorption in patients with breast cancer and bone metastases J Bone Miner Res 20 2005 1543
28. A.O. Hoff, B.B. Toth, K. Altundag Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates J Bone Miner Res 23 2008 826
29. A.I. Idris, J. Rojas, I.R. Greig, R.J. Van't Hof, S.H. Ralston Aminobisphosphonates cause osteoblast apoptosis and inhibit bone nodule formation in vitro Calcif Tissue Int 82 2008 191
30. S. Suri, J. Monkkonen, M. Taskinen Nitrogen-containing bisphosphonates induce apoptosis of Caco-2 cells in vitro by inhibiting the mevalonate pathway: A model of bisphosphonate-induced gastrointestinal toxicity Bone 29 2001 336
31. E.R. van Beek, L.H. Cohen, I.M. Leroy Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates Bone 33 2003 805
32. D. Marolt, A. Augst, L.E. Freed Bone and cartilage tissue constructs grown using human bone marrow stromal cells, silk scaffolds and rotating bioreactors Biomaterials 27 2006 6138
33. E. Malicev, D. Marolt, N. Kregar-Velikonja Growth and differentiation of alveolar bone cells in tissue-engineered constructs and monolayer cultures Biotechnol Bioeng 100 2008 773
34. H. Siggelkow, K. Rebenstorff, W. Kurre Development of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiation J Cell Biochem 75 1999 22
35. V.J. Kidd, J.M. Lahti, T. Teitz Proteolytic regulation of apoptosis Semin Cell Dev Biol 11 2000 191
36. S.L. Silverman, R. Landesberg Osteonecrosis of the jaw and the role of bisphosphonates: A critical review Am J Med 122 2009 S33
37. E.L. Scheller, P.H. Krebsbach, D.H. Kohn Tissue engineering: State of the art in oral rehabilitation J Oral Rehabil 36 2009 368
38. J.R. Berenson, L. Rosen, R. Vescio Pharmacokinetics of pamidronate disodium in patients with cancer with normal or impaired renal function J Clin Pharmacol 37 1997 285
39. L.I. Plotkin, S.C. Manolagas, T. Bellido Dissociation of the pro-apoptotic effects of bisphosphonates on osteoclasts from their anti-apoptotic effects on osteoblasts/osteocytes with novel analogs Bone 39 2006 443
40. C.R. Hoggarth, R. Bennett, P.T. Daley-Yates The pharmacokinetics and distribution of pamidronate for a range of doses in the mouse Calcif Tissue Int 49 1991 416
41. S. Leyvraz, U. Hess, G. Flesch Pharmacokinetics of pamidronate in patients with bone metastases J Natl Cancer Inst 84 1992 788
42. P. Masarachia, M. Weinreb, R. Balena, G.A. Rodan Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones Bone 19 1996 281
43. A.J. Roelofs, F.P. Coxon, F.H. Ebetino Fluorescent risedronate analogs reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo J Bone Miner Res 25 2010 606
44. F.P. Coxon, K. Thompson, A.J. Roelofs Visualizing mineral binding and uptake of bisphosphonate by osteoclasts and non-resorbing cells Bone 42 2008 848
45. H. Declercq, N. Van den Vreken, E. De Maeyer Isolation, proliferation and differentiation of osteoblastic cells to study cell/biomaterial interactions: Comparison of different isolation techniques and source Biomaterials 25 2004 757
46. R.G. Russell, N.B. Watts, F.H. Ebetino, M.J. Rogers Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy Osteoporos Int 19 2008 733
47. I.M. Twiss, O. Pas, W. Ramp-Koopmanschap The effects of nitrogen-containing bisphosphonates on human epithelial (Caco-2) cells, an in vitro model for intestinal epithelium J Bone Miner Res 14 1999 784